Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Piramal’s Mumbai Facility Gains Indian GLP Certification | Contract Pharma

What are you searching for?

Sign in
Breaking News

Piramal’s Mumbai Facility Gains Indian GLP Certification

Areas of toxicity, mutagenicity, analytical and clinical chemistry testing in compliance

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Piramal Enterprises Ltd.’s R&D facility in Goregaon, Mumbai, has received GLP Compliance Certification from the National GLP Compliance Monitoring Authority (NGCMA), Government of India. The certification covered areas of toxicity, mutagenicity, analytical and clinical chemistry testing, as well as hERG, bioanalysis and toxicokinetic evaluation.
 
The Goregaon facility provides drug discovery and development of New Chemical Entities (NCE) in the area of oncology and metabolic disorders.
 
Dr. Owe Owar, president of NCE Research, Piramal Enterprisessaid, “The GLP certification is a testament to high quality research through thorough SOP-driven Good Laboratory Practices, competent well-trained personnel and systematic documentation at Piramal’s NCE R&D facility in Mumbai. Piramal’s NCE R&D unit is committed to realize its mission towards serving patients globally with medicines that matter.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics